Jan 27, 2023
Exercise for AF, drugs have more than one effect, AI bots and
the future of medicine, and the good and bad news about prognosis
in HF are the topics John Mandrola, MD, discusses in this week’s
podcast.
This podcast is intended for healthcare professionals
only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. AF and Exercise
- Aerobic Exercise Can Reduce AF Frequency, Severity:
ACTIVE-AF https://www.medscape.com/viewarticle/957322
- An Exercise and Physical Activity Program in Patients
With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled
Trial
https://www.jacc.org/doi/full/10.1016/j.jacep.2022.12.002
- Early Rhythm-Control Therapy in Patients with Atrial
Fibrillation
https://www.nejm.org/doi/full/10.1056/NEJMoa2019422
II. GLP-1 Inhibitors and Retinopathy
- Eye Check Important Before Starting Semaglutide for
Diabetes https://www.medscape.com/viewarticle/987418
- Glucagon-like peptide 1-receptor agonists and A1c: Good
for the heart but less so for the eyes?
https://doi.org/10.1016/j.dsx.2022.102696
III. AI Bot Passes USMLEs
- AI Bot ChatGPT Passes US Medical Licensing Exams
Without Cramming – Unlike Students
https://www.medscape.com/viewarticle/987549
- Performance of ChatGPT on USMLE: Potential for
AI-Assisted Medical 2 Education Using Large Language Models
https://www.medrxiv.org/content/10.1101/2022.12.19.22283643v2.full.pdf
- Tyler Cowen Comments -- GPT and my own career
trajectory
https://marginalrevolution.com/marginalrevolution/2023/01/gpt-and-my-own-career-trajectory.html
IV. HF Prognosis
- Temporal trends in the incidence of malignancy in heart
failure: a nationwide Danish
study https://doi.org/10.1093/eurheartj/ehac797
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller
and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of
Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net